BioAtla (BCAB) Earnings Date & Reports

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCAB is expected to report earnings to fall 11.54% to -23 cents per share on August 07

Q2'25

Est.

$-0.23

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.19

Q2'24

Beat

by $0.01

The last earnings report on May 06 showed earnings per share of -25 cents, beating the estimate of -38 cents. With 178.99K shares outstanding, the current market capitalization sits at 27.63M.

View a ticker or compare two or three

Compare

BCAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BCAB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11085 Torreyana Road

Phone

+1 858 558-0708

Employees

Web

https://www.bioatla.com